COVID-19 – England – Shielding update and Q&A

Video recorded LIVE on 22/06/2020. Information correct as of this date. Now available to watch on catch up.

22 June 2020

VIDEO RECORDED LIVE on 22/6/2020.

INFORMATION CORRECT AS OF THIS DATE.

Welcome to our 3rd set of webinars on shielding. This time we are talking specifically about the guidance for patients in England.

We are joined by 3 haematologists from across England to talk about shielding and how it affects you.

Please email any questions to advocacy@leukaemiacare.org.uk

Relapsed or refractory acute myeloid leukaemia (AML)

Relapsed acute myeloid leukaemia (AML) is when AML comes back after successful treatment. Refractory AML is when AML does not respond to your first treatment. Find out what your treatment options are, and where to get support if you need it.

Read More